| EPE067 | Different Anti-Retroviral Therapy dispensing intervals and distribution of adverse follow up outcomes in stable patients | E-poster | Implementation science of scaling up HIV treatment |
| EPE068 | PMTCT option B+ implementation at the primary level of care in the Ashanti Region of Ghana; challenges | E-poster | Implementation science of scaling up HIV treatment |
| EPE069 | Impact of Daily Situation Rooms (analysis) in increasing linkage to care among people living with HIV | E-poster | Implementation science of scaling up HIV treatment |
| EPE070 | Predictors of unsuppressed viral load in pediatrics and adolescent HIV positive clients on ART in Zambia: an implementation study | E-poster | Implementation science of scaling up HIV treatment |
| EPE071 | Task-shifting and differentiation of care for nurses and outreach workers in harm reduction strengthens HIV care continuum in Kazakhstan ' Project Bridge | E-poster | Implementation science of scaling up HIV treatment |
| EPE072 | Antiretroviral drug pick-up compliance and association with viral suppression among children living with HIV in north-central Nigeria | E-poster | Implementation science of scaling up HIV treatment |
| OAE0504 | Successful transition to tenofovir/lamivudine/dolutegravir (TLD) in PEPFAR-supported countries | Oral abstract session with live Q&A | Implementation science of scaling up HIV treatment |
| PESAE07 | Long term effects of donor transition processes and their potential influence on the realization of the country's 90-90-90 targets. Experiences from a subnational level in Uganda | Poster exhibition | Implementation science of scaling up HIV treatment |
| PESAE08 | High rates of interruptions in HIV treatment in people living with HIV on ART less than three months across the age continuum | Poster exhibition | Implementation science of scaling up HIV treatment |
| EPE031 | HIV self-testing reached the our key populations regardless of COVID-19 | E-poster | Implementation science of scaling up HIV testing |